Cargando…

Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs

Detalles Bibliográficos
Autores principales: Overbeek, J.K., Heine, R. ter, Verheul, H.M.W., Chatelut, E., Rudek, M.A., Gurney, H., Plummer, R., Gilbert, D.C., Buclin, T., Burger, D.M., Bloemendal, H.J., van Erp, N.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813708/
https://www.ncbi.nlm.nih.gov/pubmed/36603522
http://dx.doi.org/10.1016/j.esmoop.2022.100749
_version_ 1784863978146496512
author Overbeek, J.K.
Heine, R. ter
Verheul, H.M.W.
Chatelut, E.
Rudek, M.A.
Gurney, H.
Plummer, R.
Gilbert, D.C.
Buclin, T.
Burger, D.M.
Bloemendal, H.J.
van Erp, N.P.
author_facet Overbeek, J.K.
Heine, R. ter
Verheul, H.M.W.
Chatelut, E.
Rudek, M.A.
Gurney, H.
Plummer, R.
Gilbert, D.C.
Buclin, T.
Burger, D.M.
Bloemendal, H.J.
van Erp, N.P.
author_sort Overbeek, J.K.
collection PubMed
description
format Online
Article
Text
id pubmed-9813708
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98137082023-01-06 Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs Overbeek, J.K. Heine, R. ter Verheul, H.M.W. Chatelut, E. Rudek, M.A. Gurney, H. Plummer, R. Gilbert, D.C. Buclin, T. Burger, D.M. Bloemendal, H.J. van Erp, N.P. ESMO Open Editorial Elsevier 2023-01-03 /pmc/articles/PMC9813708/ /pubmed/36603522 http://dx.doi.org/10.1016/j.esmoop.2022.100749 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Overbeek, J.K.
Heine, R. ter
Verheul, H.M.W.
Chatelut, E.
Rudek, M.A.
Gurney, H.
Plummer, R.
Gilbert, D.C.
Buclin, T.
Burger, D.M.
Bloemendal, H.J.
van Erp, N.P.
Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs
title Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs
title_full Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs
title_fullStr Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs
title_full_unstemmed Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs
title_short Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs
title_sort off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813708/
https://www.ncbi.nlm.nih.gov/pubmed/36603522
http://dx.doi.org/10.1016/j.esmoop.2022.100749
work_keys_str_mv AT overbeekjk offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs
AT heinerter offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs
AT verheulhmw offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs
AT chatelute offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs
AT rudekma offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs
AT gurneyh offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs
AT plummerr offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs
AT gilbertdc offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs
AT buclint offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs
AT burgerdm offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs
AT bloemendalhj offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs
AT vanerpnp offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs